An observational cohort study to assess N-acetylglucosamine for COVID-19 treatment in the inpatient setting

BACKGROUND: Coronavirus disease 2019 (COVID-19) has affected millions globally, with a continued need for effective treatments. N-acetylglucosamine has anti-inflammatory activities and modulates immune response. This study evaluated whether N-acetylglucosamine administered orally improves clinical o...

Descripción completa

Detalles Bibliográficos
Autor principal: Hassan, Ameer E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282940/
https://www.ncbi.nlm.nih.gov/pubmed/34306677
http://dx.doi.org/10.1016/j.amsu.2021.102574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282940/
https://www.ncbi.nlm.nih.gov/pubmed/34306677
http://dx.doi.org/10.1016/j.amsu.2021.102574

Ejemplares similares